Clinical Trial Update: Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the LOGIC study testing immune-modulation combined with cryoablation for triple-negative breast cancer, which is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING